Antiphospholipid antibodies in forty young patients with stroke
DOI:
https://doi.org/10.32007/jfacmedbagdad.572342Keywords:
Stroke, Antiphospholipid Syndrome, Antiphospholipid Antibodies.Abstract
Background: Cerebral ischemia associated with Antiphospholipid Syndrome(APS) is a common arterial manifestation in adults.
Objectives: To look for the frequency of Antiphospholipid Antibodies (aPL), and their relation with other risk factors in young patients with cerebral ischemia.
Patients and methods: A retrospective study of 40 young patient’s ≤ 50 years with stroke collected from medical and neurological wards of Baghdad Teaching Hospital (BTH) from January - December 2009. All were inquired about the presence of risk factors of stroke, and sent for aPL including Anticardiolipin (ACL) and Lupus Anticoagulant (LA).
Results: Eight (20%) had ACL. Nine (22.5%) had LA. Both were present in 6(15%). ACL and/or LA were present in 11 (27.5%). Thirty three (82.5) patients had at least one risk factor, 8 of them had aPL, while 7(17.5%) had no risk factor and only 3 of them had aPL (p 0.1806).
Conclusion: Antiphospholipid Syndrome is a possible risk factor of stroke and any young patient with stroke should be screened for aPL .
Downloads
Downloads
Published
Issue
Section
License
For all articles published in Journal of the Faculty of Medicine Baghdad, copyright is retained by the authors. Articles are licensed under an open access Creative Commons CC BY NC 4.0 license, meaning that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. These conditions allow for maximum use and exposure of the work, while ensuring that the authors receive proper rights.